health care reform

Viewpoint

The Limitations of Patient-Reported Outcome Measurement in Oncology

09/06/2016

Stephen P McKenna, PhD, AFBPsS, CPsychol

Generic patient-reported outcome measures (PROMs) for cancer have outlived their utility. More relevant and accurate PROMs are required in order to demonstrate the true value of oncology interventions to...

...

09/06/2016

Journal of Clinical Pathways

Interview

How Financial Distress Can Affect Cancer Care

09/06/2016

Christopher S Lathan, MD, MS, MPH

An interview with Christopher S Lathan, MD, MS, MPH, assistant professor of medicine, Harvard Medical School; faculty director, Cancer Care Equity Program; medical director, Dana-Farber Cancer Institute at St...

An...

09/06/2016

Journal of Clinical Pathways

Conference Preview

Shaping the Pathways of the Future

08/02/2016

JCP Editors

The Inaugural Clinical Pathways Congress September 16-18, 2016; Boston, MA As US expenditures on cancer-related treatments continue to grow, new solutions for managing these costs have increasingly become...

The...

08/02/2016

Journal of Clinical Pathways

Role of Pathways in Payment Reform

08/02/2016

JCP Editors

The final speaker, Blase N Polite, MD, MPP, The University of Chicago, introduced himself by saying, “My job is to convince you that pathways can fix things you don’t even know are a problem yet.” For more ASCO...

The...

08/02/2016

Journal of Clinical Pathways

Research in Review

Addressing the Unsustainable Growth of Metastatic Cancer Costs

08/02/2016

JCP Editors

Steps must be taken to address the unsustainable growth of health care costs for metastatic cancer in order to better serve patients while still acknowledging the limits of health care resources, claims a review...

Steps...

08/02/2016

Journal of Clinical Pathways

Column

Treatment Challenges in Childhood Cancer

08/02/2016

Brett Wilson

To the Editor: One of the major issues at hand in rural West Virginia is the lack of importance and impact that is given to childhood cancer, because our hospitals can make more money treating adults. Economically,...

To the...

08/02/2016

Journal of Clinical Pathways

Interview

The Potentials and Barriers of Precision Medicine in Oncology

06/20/2016

In the mid-1980s, cancer researchers shifted their focus from determining the location of a cancer to identifying the genetic mutations that create it.1 This shift gave birth to a new field of study known as...

In the...

06/20/2016

Journal of Clinical Pathways

Research in Review

FDA Approval Process Flawed for Cancer Drugs

05/30/2016

JCP Editors

A study published in Mayo Clinic Proceedings has called into question how the Food and Drug Administration (FDA) uses surrogate endpoints in approvals for certain cancer medications. Surrogate endpoints are measures...

A...

05/30/2016

Journal of Clinical Pathways

Interview

An Alliance to Reform the Current Health Care System

05/06/2016

Enacted in March of 2010, the Affordable Care Act (ACA) aimed to provide Americans with better health security through comprehensive health insurance reforms.1 Since then, the ACA has helped to significantly reduce...

...

05/06/2016

Journal of Clinical Pathways

Interview

Choosing Wisely: Addressing the Overuse of Medical Tests and Procedures

04/21/2016

JCP Editors

What methods are used to select the different recommendations that are endorsed by Choosing Wisely? What standard of evidence do you require to support these recommendations? Medical specialty societies develop...

What...

04/21/2016

Journal of Clinical Pathways